Skip to content

No results found

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

LENZ LENZ Therapeutics, Inc. Common Stock
$9.35 10.31% +0.86
Notify me if price changes either direction
Interactive Brokers Logotype

Buy LENZ stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 286.9M
Enterprise value -28155090
Trailing PE 47.984848
Forward PE -3.1885333
PEG Ratio 0.86829724952381
Enterprise to EBITDA 0.31
Enterprise to revenue -1.475
Price to book MRQ 0.92602795
Price to sales TTM 13.798036

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2025-09-30
Revenue (TTM) 19.1M
EBITDA -90851000
Diluted EPS TTM -2.85
Total Cash (MRQ) 292.3M
Current ratio (MRQ) 14.226
Operating Cash Flow (TTM) -69170000

LENZ trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent LENZ News

Home

No results found

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.